SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-059216
Filing Date
2023-05-11
Accepted
2023-05-11 17:09:03
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 tm2315013-1_s3.htm S-3 332664
2 EXHIBIT 5.1 tm2315013d2_ex5-1.htm EX-5.1 26552
3 EXHIBIT 23.1 tm2315013d2_ex23-1.htm EX-23.1 2307
4 EX-FILING FEES tm2315013d2_ex-filingfees.htm EX-FILING FEES 94514
5 GRAPHIC tm2315013d2_ex5-1img001.jpg GRAPHIC 4369
6 GRAPHIC tm2315013d2_ex5-1img002.jpg GRAPHIC 9929
  Complete submission text file 0001104659-23-059216.txt   477140
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-271848 | Film No.: 23912140
SIC: 2834 Pharmaceutical Preparations